This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Pennsylvania. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Christina A. Wilson: Innovator in Alzheimer's Disease Research
Introduction
Christina A. Wilson is a prominent inventor based in Lansdowne, PA (US). She has made significant contributions to the field of Alzheimer's disease research through her innovative work. Her research focuses on the regulation of glycogen synthase kinase-3 (GSK-3) activity, which plays a crucial role in the development of Alzheimer's disease.
Latest Patents
Christina A. Wilson holds a patent for the "Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease." This patent describes a novel use of therapeutic concentrations of GSK-3 inhibitors, including lithium, to block or reduce the processing of amyloid precursor proteins into beta-amyloid peptides. These peptides are believed to be the principal cause of Alzheimer's disease. The patent also outlines methods for using agents that specifically target the α isoform of GSK-3, making these selective inhibitors particularly useful in treating, preventing, and potentially reversing Alzheimer's disease. Additionally, the patent includes kits and screening methods associated with these innovative approaches.
Career Highlights
Christina A. Wilson is affiliated with the University of Pennsylvania, where she continues her research and development efforts. Her work has garnered attention for its potential impact on Alzheimer's disease treatment and prevention. With her dedication to scientific advancement, she has established herself as a key figure in her field.
Collaborations
Christina collaborates with esteemed colleagues, including Christopher J. Phiel and Virginia Man-Yee Lee. These partnerships enhance her research efforts and contribute to the advancement of knowledge in Alzheimer's disease.
Conclusion
Christina A. Wilson's innovative work in Alzheimer's disease research highlights her commitment to finding effective treatments and prevention strategies. Her patent on GSK-3 inhibitors represents a significant step forward in understanding and combating this devastating disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile